|
1
|
Findlay JM, Middleton MR and Tomlinson I:
A systematic review and meta-analysis of somatic and germline DNA
sequence biomarkers of esophageal cancer survival, therapy response
and stage. Ann Oncol. 26:624–644. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Malik MA, Zargar SA and Mittal B: Role of
NQO1 609C>T and NQO2-3423G>A gene polymorphisms in esophageal
cancer risk in Kashmir valley and meta analysis. Mol Biol Rep.
39:9095–9104. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chen M, Cai E, Huang J, Yu P and Li K:
Prognostic value of vascular endothelial growth factor expression
in patients with esophageal cancer: A systematic review and
meta-analysis. Cancer Epidemiol Biomarkers Prev. 21:1126–1134.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Jacobs M, Macefield RC, Blazeby JM,
Korfage IJ, van Berge Henegouwen MI, de Haes HC, Smets EM and
Sprangers MA: Systematic review reveals limitations of studies
evaluating health-related quality of life after potentially
curative treatment for esophageal cancer. Qual Life Res.
22:1787–1803. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Samson P, Robinson C, Bradley J, Lockhart
AC, Puri V, Broderick S, Kreisel D, Krupnick AS, Patterson GA,
Meyers B and Crabtree T: Neoadjuvant chemotherapy versus
chemoradiation prior to esophagectomy: Impact on rate of complete
pathologic response and survival in esophageal cancer patients. J
Thorac Oncol. 11:2227–2237. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Liao J, Liu R, Shi YJ, Yin LH and Pu YP:
Exosome-shuttling microRNA-21 promotes cell migration and
invasion-targeting PDCD4 in esophageal cancer. Int J Oncol.
48:2567–2579. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Guo J, Yu X, Gu J, Lin Z, Zhao G, Xu F, Lu
C and Ge D: Regulation of CXCR4/AKT-signaling-induced cell invasion
and tumor metastasis by RhoA, Rac-1, and Cdc42 in human esophageal
cancer. Tumour Biol. 37:6371–6378. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Pan Z, Mao W, Bao Y, Zhang M, Su X and Xu
X: The long noncoding RNA CASC9 regulates migration and invasion in
esophageal cancer. Cancer Med. 5:2442–2447. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Shi H, Shi D, Wu Y, Shen Q and Li J:
Qigesan inhibits migration and invasion of esophageal cancer cells
via inducing connexin expression and enhancing gap junction
function. Cancer Lett. 380:184–190. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Schiefer AI, Schoppmann SF and Birner P:
Lymphovascular invasion of tumor cells in lymph node metastases has
a negative impact on survival in esophageal cancer. Surgery.
160:331–340. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yokota T, Igaki H, Kato K, Tsubosa Y,
Mizusawa J, Katayama H, Nakamura K, Fukuda H and Kitagawa Y:
Accuracy of preoperative diagnosis of lymph node metastasis for
thoracic esophageal cancer patients from JCOG9907 trial. Int J Clin
Oncol. 21:283–288. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Visser E, Leeftink AG, van Rossum PS,
Siesling S, van Hillegersberg R and Ruurda JP: Waiting time from
diagnosis to treatment has no impact on survival in patients with
esophageal cancer. Ann Surg Oncol. 23:2679–2689. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ishigaki M, Maeda Y, Taketani A, Andriana
BB, Ishihara R, Wongravee K, Ozaki Y and Sato H: Diagnosis of
early-stage esophageal cancer by Raman spectroscopy and chemometric
techniques. Analyst. 141:1027–1033. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kawada S and Imai Y: Diagnosis of
esophageal cancer and metastatic lymph node using CT and MRI. Nihon
Rinsho. 69 Suppl 6:S174–S181. 2011.(In Japanese).
|
|
15
|
Freling N, Roele E, Schaefer-Prokop C and
Fokkens W: Prediction of deep neck abscesses by contrast-enhanced
computerized tomography in 76 clinically suspect consecutive
patients. Laryngoscope. 119:1745–1752. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yang DH, Min JJ, Jeong YY, Ahn JS, Kim YK,
Cho SH, Chung IJ, Bom HS, Kim HJ and Lee JJ: The combined
evaluation of interim contrast-enhanced computerized tomography
(CT) and FDG-PET/CT predicts the clinical outcomes and may impact
on the therapeutic plans in patients with aggressive non-Hodgkin's
lymphoma. Ann Hematol. 88:425–432. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kanat O, O'Neil B and Shahda S: Targeted
therapy for advanced gastric cancer: A review of current status and
future prospects. World J Gastrointestinal Oncol. 7:401–410. 2015.
View Article : Google Scholar
|
|
18
|
Kakimoto N, Chindasombatjaroen J, Tomita
S, Shimamoto H, Uchiyama Y, Hasegawa Y, Kishino M, Murakami S and
Furukawa S: Contrast-enhanced multidetector computerized tomography
for odontogenic cysts and cystic-appearing tumors of the jaws: Is
it useful? Oral Surg Oral Med Oral Pathol Oral Radiol. 115:104–113.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Mazzei MA, Guerrini S, Mazzei FG,
Squitieri Cioffi N, Notaro D, de Donato G, Galzerano G, Sacco P,
Setacci F, Volterrani L and Setacci C: Follow-up of endovascular
aortic aneurysm repair: Preliminary validation of digital
tomosynthesis and contrast enhanced ultrasound in detection of
medium- to long-term complications. World J Radiol. 8:530–536.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Schalk S, Demi L, Bouhouch N, Kuenen MPJ,
Postema AW, de la Rosette JJMCH, Wijkstra H, Tjalkens TJ and Mischi
M: Contrast-enhanced Ultrasound Angiogenesis Imaging by mutual
information analysis for prostate cancer localization. IEEE Trans
Biomed Eng. 64:661–670. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Shi H, Wang Z, Huang C, Gu X, Jia T, Zhang
A, Wu Z, Zhu L, Luo X, Zhao X, et al: A functional ct contrast
agent for in vivo imaging of tumor hypoxia. Small. 12:3995–4006.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wheatley MA, Forsberg F, Dube N, Patel M
and Oeffinger BE: Surfactant-stabilized contrast agent on the
nanoscale for diagnostic ultrasound imaging. Ultrasound Med Biol.
32:83–93. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Fons P, Gueguen-Dorbes G, Herault JP,
Geronimi F, Tuyaret J, Frédérique D, Schaeffer P, Volle-Challier C,
Herbert JM and Bono F: Tumor vasculature is regulated by FGF/FGFR
signaling-mediated angiogenesis and bone marrow-derived cell
recruitment: This mechanism is inhibited by SSR128129E, the first
allosteric antagonist of FGFRs. J Cell Physiol. 230:43–51. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Valesky M, Spang AJ, Fisher GW, Farkas DL
and Becker D: Noninvasive dynamic fluorescence imaging of human
melanomas reveals that targeted inhibition of bFGF or FGFR-1 in
melanoma cells blocks tumor growth by apoptosis. Mol Med.
8:103–112. 2002.PubMed/NCBI
|
|
25
|
Takahashi O, Komaki R, Smith PD,
Jürgensmeier JM, Ryan A, Bekele BN, Wistuba II, Jacoby JJ,
Korshunova MV, Biernacka A, et al: Combined MEK and VEGFR
inhibition in orthotopic human lung cancer models results in
enhanced inhibition of tumor angiogenesis, growth, and metastasis.
Clin Cancer Res. 18:1641–1654. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Bozec A, Formento P, Lassalle S, Lippens
C, Hofman P and Milano G: Dual inhibition of EGFR and VEGFR
pathways in combination with irradiation: Antitumour supra-additive
effects on human head and neck cancer xenografts. Br J Cancer.
97:65–72. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yang Z, Lu A, Wong BC, Chen X, Bian Z,
Zhao Z, Huang W, Zhang G, Chen H and Xu M: Effect of liposomes on
the absorption of water-soluble active pharmaceutical ingredients
via oral administration. Curr Pharm Des. 19:6647–6654. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chen CL, Hu GY, Mei Q, Qiu H, Long GX and
Hu GQ: Epidermal growth factor receptor-targeted ultra-small
superparamagnetic iron oxide particles for magnetic resonance
molecular imaging of lung cancer cells in vitro. Chin Med J (Engl).
125:2322–2328. 2012.PubMed/NCBI
|
|
29
|
Granja RH, Salerno AG, de Lima AC,
Montalvo C, Reche KV, Giannotti FM and Wanschel AC: Liquid
chromatography/tandem mass spectrometry method to determine
boldenone in bovine liver tissues. J AOAC Int. 97:1476–1480. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ghantous Y, Naddaf R, Barak M, Abd-Elraziq
M and Eln-Naaj Abu I: The role of fine needle aspiration in the
diagnosis of parotid gland tumors: Correlation with preoperative
computerized tomography tumor size. J Craniofac Surg. 27:e192–e196.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Angelov KG, Vasileva MB, Grozdev KS,
Sokolov MB and Todorov G: Clinical and pathological
characteristics, and prognostic factors for gastric cancer survival
in 155 patients in Bulgaria. Hepatogastroenterology. 61:2421–2424.
2014.PubMed/NCBI
|
|
32
|
Sawasdikosol S: Detecting
tyrosine-phosphorylated proteins by Western blot analysis. Curr
Protoc Immunol Chapter. 11:Unit 11 13. 11. 2010.
|
|
33
|
Dirani M, Nasreddine W, Abdulla F and
Beydoun A: Seizure control and improvement of neurological
dysfunction in Lafora disease with perampanel. Epilepsy Behav Case
Rep. 2:164–166. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kargahi N, Razavi SM, Deyhimi P and
Homayouni S: Comparative evaluation of eosinophils in normal
mucosa, dysplastic mucosa and oral squamous cell carcinoma with
hematoxylin-eosin, Congo red, and EMR1 immunohistochemical staining
techniques. Electron Physician. 7:1019–1026. 2015.PubMed/NCBI
|
|
35
|
Wei R, Guo B and Tan ZM: Application of
tumor markers detection in early diagnosis of oral
maxillofacial-head and neck carcinomas. Zhonghua Kou Qiang Yi Xue
Za Zhi. 43:143–145. 2008.(In Chinese). PubMed/NCBI
|
|
36
|
Neven P, Brouckaert O, Van Belle V, Vanden
Bempt I, Hendrickx W, Cho H, Deraedt K, Van Calster B, Van Huffel
S, Moerman P, et al: In early-stage breast cancer, the estrogen
receptor interacts with correlation between human epidermal growth
factor receptor 2 status and age at diagnosis, tumor grade, and
lymph node involvement. J Clin Oncol. 26:1768–1771. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Ebell MH, Culp MB and Radke TJ: A
systematic review of symptoms for the diagnosis of ovarian cancer.
Am J Prev Med. 50:384–394. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
de Moura PM, Hallac R, Kane A and Seaward
J: Improving the evaluation of alveolar bone grafts with cone beam
computerized tomography. Cleft Palate Craniofac J. 53:57–63. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Fang L, Jingjing L, Ying S, Lan M, Tao W
and Nan J: Computerized tomography-guided sphenopalatine ganglion
pulsed radiofrequency treatment in 16 patients with refractory
cluster headaches: Twelve- to 30-month follow-up evaluations.
Cephalalgia. 36:106–112. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Benharroch D, Shvarts S, Jotkowitz A and
Shelef I: Computerized tomography scanning and magnetic resonance
imaging will terminate the era of the autopsy-a hypothesis. J
Cancer. 7:115–120. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Lambert S, Al-Hadithy N, Sewell MD, Hertel
R, Südkamp N, Noser H and Kamer L: Computerized tomography based 3D
modeling of the clavicle. J Orthop Res. 34:1216–1223. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Kim M, Lee JH, Kim SE, Kang SS and Tae G:
Nanosized ultrasound enhanced-contrast agent for in vivo tumor
imaging via intravenous injection. ACS Appl Mater Interfaces.
8:8409–8418. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Ding W, Lou C, Qiu J, Zhao Z, Zhou Q,
Liang M, Ji Z, Yang S and Xing D: Targeted Fe-filled carbon
nanotube as a multifunctional contrast agent for thermoacoustic and
magnetic resonance imaging of tumor in living mice. Nanomedicine.
12:235–244. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Wang W, Li J, Liu R, Zhang A and Yuan Z:
Size effect of Au/PAMAM contrast agent on CT imaging of
reticuloendothelial system and tumor tissue. Nanoscale Res Lett.
11:4292016. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Konduru N, Keller J, Ma-Hock L, Gröters S,
Landsiedel R, Donaghey TC, Brain JD, Wohlleben W and Molina RM:
Biokinetics and effects of barium sulfate nanoparticles. Part Fibre
Toxicol. 11:552014. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Liss P, Hansell P, Fasching A and Palm F:
Iodinated contrast media inhibit oxygen consumption in freshly
isolated proximal tubular cells from elderly humans and diabetic
rats: Influence of nitric oxide. Ups J Med Sci. 121:12–16. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Mishra SK, Kumar BS, Khushu S, Tripathi RP
and Gangenahalli G: Increased transverse relaxivity in ultrasmall
superparamagnetic iron oxide nanoparticles used as MRI contrast
agent for biomedical imaging. Contrast Media Mol Imaging.
11:350–361. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Kitoh Y: 5. Inspection of hepatocellular
carcinoma 3-contrast for the diagnosis of hepatocellular carcinoma:
Techniques of image contrast and the choice of MR contrast agent.
Nihon Hoshasen Gijutsu Gakkai Zasshi. 72:441–451. 2016.(In
Japanese). View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Zhang J, Liu J, Wang LM, Li ZY and Yuan Z:
Retroreflective-type Janus microspheres as a novel contrast agent
for enhanced optical coherence tomography. J Biophotonics.
10:878–886. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
D'Hollander A, Mathieu E, Jans H, Vande
Velde G, Stakenborg T, Van Dorpe P, Himmelreich U and Lagae L:
Development of nanostars as a biocompatible tumor contrast agent:
Toward in vivo SERS imaging. Int J Nanomedicine. 11:3703–3714.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Huang YM, Wang CH, Huang JS, Tsai CS, Yeh
KY, Lan YJ, Wu TH, Chang PH, Chang YS and Lai CH:
Treatment-associated severe thrombocytopenia affects survival rate
in esophageal cancer patients undergoing concurrent
chemoradiotherapy. Indian J Cancer. 52:454–460. 2015. View Article : Google Scholar : PubMed/NCBI
|
